Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario / Factors associated with success of a smoking cessation program
Rev. méd. Chile
; 144(8): 965-971, ago. 2016. ilus, tab
Article
in Es
| LILACS
| ID: biblio-830600
Responsible library:
CL1.1
ABSTRACT
Background:
Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available.Aim:
To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients andMethods:
Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program.Results:
The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction level of more than 12 years was associated with a lower failure rate (OR 0.38 95% CI 0.18-0.82).Conclusions:
A high tobacco dependence rate and a lower education were associated with a higher failure rate of this smoking cessation program.Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Program Evaluation
/
Smoking
/
Smoking Cessation
/
Nicotinic Agonists
/
Varenicline
Type of study:
Evaluation_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Es
Journal:
Rev. méd. Chile
Journal subject:
MEDICINA
Year:
2016
Document type:
Article
Affiliation country:
Chile
Country of publication:
Chile